ITOS: iTeos Therapeutics, Inc. Market Value
iTeos Therapeutics (ITOS) ensures stable supplies of immuno-oncology components, maintaining high margins through its warehouse network. The company strictly adheres to environmental regulations by implementing energy saving and emission filtration in its laboratories. This chart shows share price quotes fixed at 0.45. Business development relies on partnerships with pharma behemoths and the expansion of the TIGIT inhibitor database within the R&D cycle.
Comprehensive metric breakdowns and analytics for iTeos Pharma (ITOS)
- stock price and consensus target price:
- market capitalization information:
- book value of equity indicators:
- debt and liquidity data:
Total Debt to Capital iTeos Therapeutics|ITOS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital iTeos Therapeutics|ITOS - Company Aggregate Debts|Debt to Book Capitalization Ratio iTeos Pharma|ITOS - Company Long-Term Loans and Borrowings|Company Short-Term Debt iTeos Therapeutics|Quick Ratio iteostherapeutics.com
- business earnings and investment ratios data:
ITOS - Net Profit|Future Profit iTeos Therapeutics|ITOS - Company Value to Net Income|Forward P/E Multiple iTeos|ITOS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iTeos Pharma|ITOS - Operating profit before deduction of amortization|Earnings per share for the last twelve months iTeos Therapeutics|ITOS - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months iteostherapeutics.com|ITOS - Earnings growth in current year|Net earnings per share growth forecast for next year iTeos Therapeutics
Fundamental company analysis:ITOS (iTeos Therapeutics, Inc.)
Market capitalization reflects the real-time current value of the business. This indicator is calculated as the product of the current share price and the total number of shares outstanding, capturing instantaneous fluctuations in value. Analyzing the capitalization size of a public company allows for the identification of long-term trends and valuation inertia. For iTeos Therapeutics (ITOS), this metric is sensitive to the success of belarestug. Inelastic demand for unique TIGIT inhibitors provides the company with significant pricing power.
Key competitors
argenx - Market Valuation|Market Value BNTX (BioNTech Inc.)|ABVX - Market Value|Market Value ADMA Corp|Protagonist Therapeutics (PTGX) - Market Value|IMVT - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Market Capitalization Aerovate Therapeutics Inc JBIO|ACRS (Aclaris Therapeutics) - Market Valuation|KYTX: Market Value|TLSA (Tiziana Life Sciences Ltd) - Market Capitalization|Market Value Cabaletta Bio Inc. CABA|Market Value Ventyx Bio (VTYX)|THTX - Market Value|Market Value Avalo Therapeutics, Inc AVTX|Market Capitalization eledon.com (ELDN)|AGEN: Market Valuation|Market Value CLYM (Climb Bio Inc.)|ZURA (Zura Bio) - Market Valuation|ATYR: Market Value|ADAG (Adagene Inc) - Market Capitalization|IMA: Market Value|Market Capitalization STTK|EQ - Market Value|Market Value Connect Biopharma Holdings Limited CNTB|Market Value IMUX|Atara Biotherapeutics Inc - Market Capitalization|IFRX - Market Capitalization|X4 Pharmaceuticals, Inc. (XFOR) - Market Value|Market Valuation ACET (Adicet Bio, Inc.)|CELU (Celularity Inc) - Market Capitalization|Market Value INmune Bio Corporation INMB|Market Valuation BRNS (Barinthus Biotherapeutics)|Market Capitalization kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Market Valuation|Market Value AKTX (Akari Therapeutics PLC)|Enlivex Therapeutics, Ltd. - Market Capitalization|Market Capitalization Q32 Bio Inc. QTTB|GOVX: Market Capitalization|Market Valuation edesabiotech.com|Market Value iBio|Carisma Tx (CARM) - Market Capitalization|Market Capitalization XTLB|Market Capitalization boltbio.com|HCW Biologics - Market Valuation|Market Value APVO (Aptevo Therapeutics, Inc.)|AIM - Market Value|Market Value Aditxt|GRI Bio Corp (GRI) - Market Value|XRTX - Market Capitalization|Market Value Vyome Holdings Inc|revbiosciences.com - Market Valuation|Market Capitalization INDP|SCNI (Scinai Immunotherapeutics Ltd) - Market Value|Market Capitalization CALI (CalciMedica)|Market Capitalization Affimed NV AFMD|ALLK - Market Value|Market Value HOOK (HOOKIPA Pharma Inc.)|igmbio.com (IGMS) - Market Value|Market Valuation Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Market Capitalization|Market Capitalization Third Harmonic Bio Inc
